跳至主要内容
临床试验/NCT03600688
NCT03600688进行中(未招募)不适用

Transcatheter Repair of Mitral Regurgitation With Cardioband System Post Market Study:A European Prospective, Multicenter Study to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System in Patients With Symptomatic MR

Edwards Lifesciences17 个研究点 分布在 3 个国家目标入组 200 人开始时间: 2018年6月6日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
200
试验地点
17
主要终点
Procedure Success at discharge

研究概览

简要总结

To demonstrate reduction of MR with durable performance and im-provements in functional status

详细描述

MiBAND is a prospective, single arm, European post-market study to assess the safety and efficacy of the Edwards Cardioband system. Patients will be followed up at 30D, 6months, 1, 2 and 3 years.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years;
  • MR (≥ 2+ by echocardiography);
  • Patient is eligible to receive the Edwards Cardioband Mitral System

排除标准

  • Active bacterial endocarditis
  • Severe organic lesions with retracted chordae or congenital mal-formations with lack of valvular tissue
  • Heavily calcified annulus or leaflets
  • Patients in whom transesophageal echocardiography is contraindicated
  • Patients who cannot tolerate an anticoagulation/antiplatelet regimen
  • Patients with known severe reaction to contrast agents that cannot be adequately pre-medicated.
  • Pre-existing prosthetic heart valve or annuloplasty in the Mitral position
  • Life expectancy of less than twelve months
  • Patient is pregnant or lactating

结局指标

主要结局

Procedure Success at discharge

时间窗: Hospital discharge; approximately 2-8 days post-procedure

Reduction in Severity of Mitral Regurgitation at discharge

次要结局

  • Procedure Success(30 days, 6months, 1, 2 and 3 years)
  • Major Adverse Events Rate(30 days, 6months, 1, 2 and 3 years)
  • Change in Quality Of Life-KCCQ(30 days, 6 months, 1, 2 and 3 years)
  • Change in Quality Of Life-EQ-5D-5L(30 days, 6 months, 1, 2 and 3 years)

研究者

发起方
Edwards Lifesciences
申办方类型
Industry
责任方
Sponsor

研究点 (17)

Loading locations...

相似试验

Edwards Cardioband European Post-Market Study, MiBAND | 临床试验